Nyxoah SA (EBR:NYXH)
Belgium · Delayed Price · Currency is EUR 1.310
-0.038 (-2.82%)
At close: Sep 18, 2026
Nyxoah Market Cap
Nyxoah has a market cap or net worth of €131.1 million as of September 18, 2026. Its market cap has decreased by -11.60% in one year.
Market Cap
131.10M
Enterprise Value
93.30M
Revenue
21.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.31
ChartMarket Cap Chart
Since September 18, 2020, Nyxoah's market cap has decreased from 417.77M to 131.10M, a decrease of -68.62%. That is a compound annual growth rate of -17.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 131.10M | -25.41% |
| Dec 31, 2025 | 175.76M | -43.15% |
| Dec 31, 2024 | 309.15M | 153.09% |
| Dec 29, 2023 | 122.15M | -8.05% |
| Dec 30, 2022 | 132.85M | -72.29% |
| Dec 31, 2021 | 479.37M | 37.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 54.28B |
| UCB SA | 39.77B |
| Financière de Tubize | 7.91B |
| Fagron NV | 1.63B |
| Ion Beam Applications | 443.89M |
| Onward Medical | 200.94M |
| Hyloris Pharmaceuticals | 118.16M |
| Sequana Medical NV | 43.56M |